1-3 of 3
Lauren Tyrell
Close
Sort by
Journal Articles

Activity of SYK and PLCĪ³2 Predict Apoptotic Response of Chronic Lymphocytic Leukemia Cells to SRC Tyrosine Kinase Inhibitor Dasatinib.

Y. Lynn Wang, MD, PhD, Zibo Song, Pin Lu, Richard R Furman, John P. Leonard, MD, Peter Martin, Lauren Tyrell, Francis Y. Lee, Daniel M. Knowles, Morton Coleman
Journal: Blood
Blood (2009) 114 (22): 1249.
https://doi.org/10.1182/blood.V114.22.1249.1249
Published: 2009
Journal Articles

ZAP-70 Expression Assessed by Immunohistochemistry Correlates with Time to First Treatment in Patients with Chronic Lymphocytic Leukemia.

Peter Martin, Amy Chadburn, MD, Wayne Tam, Lauren Tyrell, Rebecca Elstrom, MD, Jia Ruan, MD, PhD, Morton Coleman, Scott Ely, MD, MPH, Daniel M. Knowles, John P. Leonard, Richard R Furman
Journal: Blood
Blood (2009) 114 (22): 4686.
https://doi.org/10.1182/blood.V114.22.4686.4686
Published: 2009
Journal Articles

Levels of Circulating Endothelial Cells and Endothelial Progenitors Correlate with Disease Status and Treatment Response in Human Lymphoma Subtypes of CLL and MCL.

Jia Ruan, MD, PhD, Maureen Ward, MA, Lei Fan, MD, PhD, Adam Faye, Maureen Lane, PhD, Katherine A. Hajjar, MD, Lauren Tyrell, Peter Martin, MD, Rebecca Elstrom, MD, Morton Coleman, MD, Richard R Furman, John P. Leonard, MD
Journal: Blood
Blood (2009) 114 (22): 3941.
https://doi.org/10.1182/blood.V114.22.3941.3941
Published: 2009